Life Sciences at Goldman Sachs Alternatives Investment Portfolio
Life Sciences at Goldman Sachs Alternatives is the life sciences investment team within Goldman Sachs Asset Management’s Alternatives platform. The team makes private investments in biotechnology, pharmaceutical and medical technology companies, providing growth- and venture-stage capital across the life sciences sector.Healthcare, Biotechnology & Medical Devices
$75.00M
Series C
Healthcare, Biotechnology & Medical Devices
$52.00M
Series A